Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls77_0002.txt
Subject: BIOLOGICAL WARFARE VACCINATION GUIDELINES
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: BIOLOGICAL WARFARE VACCINATION GUIDELINES-2
Document Number: 1
Folder SEQ #: 203
primary protection against botulinum toxin is the use of your
chemical protective mask and overgarment. Vaccination with
botulinum toxoid is expected to provide additional protection for
individuals exposed to the toxin. However, no vaccine is 100%
effective. No other vaccine is available which can give you this
protection.
This is an investigational (not yet licensed) vaccine that
has been safely given to over 3,000 laboratory workers and
scientists over the past 25 years. it will be administered as a
series of three injections under the supervision of qualified
medical personnel.
About 92% of people who are vaccinated report no significant
side effects beyond the local pain experienced at the time the
vaccine is given. However, like other vaccines you have been
given, this one may have some side effects. Side effects occur
in 4% to 8% of people. When they occur, they are usually at the
site of injection and include pain, tenderness, swelling,
redness, and/or itching. All these are common symptoms with the
typhoid vaccine you have already received. The number of these
local reactions tends to increase after the first injection.
Rarely an individual may develop a small lump at the injection
site which lasts for several days to weeks before going away.
Local reactions that can interfere with performance of your
duties are muscle pain and occur in less than 1% of people.
Rarely (less than 1 in 1,000 injections) an individual may be
unable to perform duties for a day or two. As with any
vaccination, a very rare, unexpected, potentially severe, side
effect not previously observed could occur. If you are pregnant
it is not known if this vaccine will harm your unborn baby.
the mother.
If a reaction that worries you occurs after you leave the
area where the vaccine was given you should report to sick call.
The fact that you are receiving these shots is classified
and you are not to discuss these shots with anyone.
UNCLASSIFIED
C. The above statement is not to be distributed.
D. Rosters of personnel receiving vaccine will be
maintained and will include name, SSN, rank, and unit.
E. Vaccinations may be recorded on PHS-731 (yellow shot
record) or on SF-601 (Immunization Record). The first botulinum
toxoid vaccination will be recorded as Vacc B. The second
botulinum toxoid vaccination will be recorded as Vacc B-2 and the
third botulinum toxoid vaccination will be recorded as Vacc B-3.
5. Component surgeons should disseminate the contents of
this message to the appropriate level of health care providers.
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 3 f:/Week-36/BX003203/BIOLOGICAL WARFARE VACCINATION GUIDELINES-2/biological warfare vaccination guidelines:11259610131717
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BIOLOGICAL WARFARE VACCINATION GUIDELINES-2
Folder Seq # = 203
Subject = BIOLOGICAL WARFARE VACCINATION GUIDELINES
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-NOV-1996